000 | 01727 a2200529 4500 | ||
---|---|---|---|
005 | 20250513231915.0 | ||
264 | 0 | _c20010222 | |
008 | 200102s 0 0 eng d | ||
022 | _a0250-7005 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBellino, R | |
245 | 0 | 0 |
_aEpidoxorubicin and paclitaxel as primary chemotherapy for T > 3 cm and T4 breast cancer patients. _h[electronic resource] |
260 |
_bAnticancer research _c |
||
300 |
_a4825-8 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Journal Article; Multicenter Study | ||
650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadministration & dosage |
650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
650 | 0 | 4 | _aChemotherapy, Adjuvant |
650 | 0 | 4 |
_aCyclophosphamide _xadministration & dosage |
650 | 0 | 4 | _aDisease Progression |
650 | 0 | 4 | _aDisease-Free Survival |
650 | 0 | 4 |
_aEpirubicin _xadministration & dosage |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aFluorouracil _xadministration & dosage |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aLymph Node Excision |
650 | 0 | 4 | _aLymphatic Metastasis |
650 | 0 | 4 | _aMastectomy, Modified Radical |
650 | 0 | 4 | _aMastectomy, Segmental |
650 | 0 | 4 |
_aMethotrexate _xadministration & dosage |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aNeoplasm Metastasis |
650 | 0 | 4 | _aNeoplasm Staging |
650 | 0 | 4 |
_aPaclitaxel _xadministration & dosage |
700 | 1 | _aCortese, P | |
700 | 1 | _aDanese, S | |
700 | 1 | _aDe Sanctis, C | |
700 | 1 | _aDurando, A | |
700 | 1 | _aGenta, F | |
700 | 1 | _aGrio, R | |
700 | 1 | _aGiardina, G | |
700 | 1 | _aKatsaros, D | |
700 | 1 | _aMassobrio, M | |
700 | 1 | _aRichiardi, G | |
700 | 1 | _aVicelli, R | |
773 | 0 |
_tAnticancer research _gvol. 20 _gno. 6C _gp. 4825-8 |
|
999 |
_c11143268 _d11143268 |